(0.19%) 5 258.27 points
(0.16%) 39 825 points
(-0.05%) 16 391 points
(2.00%) $82.98
(1.69%) $1.747
(1.23%) $2 239.90
(0.99%) $25.00
(1.35%) $921.95
(0.39%) $0.927
(0.80%) $10.85
(0.13%) $0.792
(0.14%) $92.57
Live Chart Being Loaded With Signals
Oncimmune Holdings plc develops and commercializes technologies that enable cancer diagnosis in the United Kingdom, North America, Europe, and internationally...
Stats | |
---|---|
Today's Volume | 12 949.00 |
Average Volume | 71 764.00 |
Market Cap | 15.38M |
EPS | £0 ( 2023-09-28 ) |
Last Dividend | £0 ( N/A ) |
Next Dividend | £0 ( N/A ) |
P/E | -1.480 |
ATR14 | £0 (0.00%) |
Oncimmune Holdings PLC Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Oncimmune Holdings PLC Financials
Annual | 2022 |
Revenue: | £1.15M |
Gross Profit: | £792 000 (68.75 %) |
EPS: | £0.0565 |
Q1 | 2023 |
Revenue: | £28 000.00 |
Gross Profit: | £28 000.00 (100.00 %) |
EPS: | £0.110 |
Q3 | 2022 |
Revenue: | £1.12M |
Gross Profit: | £344 000 (30.60 %) |
EPS: | £-0.0580 |
Q1 | 2021 |
Revenue: | £127 250 |
Gross Profit: | £-7 000.00 (-5.50 %) |
EPS: | £-0.0334 |
Financial Reports:
No articles found.
Oncimmune Holdings PLC
Oncimmune Holdings plc develops and commercializes technologies that enable cancer diagnosis in the United Kingdom, North America, Europe, and internationally. It offers EarlyCDT-Lung, a immunodiagnostic test for detecting and identifying lung cancer. The company also develops SeroTag, a platform that is used to discover and validate biomarkers for stratifying patients in multiple cancer indications, infectious diseases, and with various autoimmune diseases; and NavigAID, a disease-specific characterization panel. Oncimmune Holdings plc was incorporated in 2015 and is based in Nottingham, the United Kingdom.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators